Previous Close | 0.4000 |
Open | 0.4100 |
Bid | 0.4200 x 0 |
Ask | 0.4500 x 0 |
Day's Range | 0.4000 - 0.4450 |
52 Week Range | 0.3750 - 1.2000 |
Volume | |
Avg. Volume | 202,520 |
Market Cap | 99.312M |
Beta (5Y Monthly) | 1.88 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -0.0540 |
Earnings Date | May 02, 2022 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 1.46 |
Vancouver, British Columbia--(Newsfile Corp. - May 12, 2022) - good natured Products Inc. (TSXV: GDNP) (the "Company" or "good natured®"), a North American leader in plant-based products, announced that the Company, and Beacon Securities Limited and National Bank Financial Inc., the co-lead underwriters for the previously announced bought deal offering of units (the "Offering") of the Company as described in the Company's press releases of May 4, 2022 and May 5, 2022, have ...
Good natured Products Inc. (the "Company" or "good natured®") (TSXV: GDNP), a North American leader in plant-based products, today announced that it will be seeking a 5 business day extension of the time period to file the prospectus supplement for its previously announced bought deal offering of units (the "Offering") described in the Company's press releases of May 4, 2022 and May 5, 2022, pending resolution of an issue described further below.